Acceptability and Feasibility of Home-based TB Testing

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

June 30, 2019

Conditions
Tuberculosis, PulmonaryHouseholds
Interventions
DIAGNOSTIC_TEST

Home-based point-of-care (POC) TB testing using GeneXpert device + MTB/RIF test

Those who screen positive for TB using the standard 4-question screener will be offered a GeneXpert® \[Cepheid, Sunnyvale, CA\] MTB/RIF test in their home with referral for clinic-based TB treatment initiation for those who receive a positive MTB/RIF test result.

Trial Locations (1)

5217

Buffalo City Metro, East London

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)

NIH

collaborator

Medical Research Council, South Africa

OTHER

collaborator

Foundation for Innovative New Diagnostics, Switzerland

OTHER

collaborator

University of Witwatersrand, South Africa

OTHER

collaborator

University of California, Irvine

OTHER

lead

Foundation for Professional Development (Pty) Ltd

OTHER

NCT04973371 - Acceptability and Feasibility of Home-based TB Testing | Biotech Hunter | Biotech Hunter